Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8738644 | International Journal of Antimicrobial Agents | 2018 | 15 Pages |
Abstract
Infections due to multidrug-resistant bacteria (MDR) are currently a clinical challenge, mainly in elderly patients. The antimicrobial spectrum, safety and efficacy of ceftolozane/tazobactam (C/T) make it an attractive option for the treatment of MDR bacterial infections beyond the indications approved to date. Here we report our experience with C/T in four cases of osteomyelitis and three cases of skin and soft-tissue infections due to extensively-drug-resistant Pseudomonas aeruginosa.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
B. Dietl, I. Sánchez, P. Arcenillas, E. Cuchi, L. Gómez, F.J. González de Molina, L. Boix-Palop, J. Nicolás, E. Calbo,